Brief: Akebia Therapeutics Inc - On Aug 11, Nasdaq Informed Co Is Not In Compliance With Nasdaq Listing Rule 5250(C)
17/08/2023 22:38
Akebia Therapeutics Inc AKBA.O :
* AKEBIA THERAPEUTICS INC - ON AUG 11, NASDAQ INFORMED CO IS
NOT
IN COMPLIANCE WITH NASDAQ LISTING RULE 5250(C)
* AKEBIA THERAPEUTICS INC - CO HAS UNTIL OCT 10 TO SUBMIT A
PLAN
TO REGAIN COMPLIANCE WITH LISTING RULE
Source text for Eikon: ID:
Further company coverage: AKBA.O
Recent news on Akebia Therapeutics
See all newsAkebia Q1 revenue falls, net income misses analyst estimates on higher expenses
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers To Its Board Of Directors
Akebia posts wider-than-expected Q4 net loss as higher expenses hurt
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule